Home > Healthcare > Orthopedic Padding Market
Orthopedic Padding Market Size
Orthopedic Padding Market size is anticipated to witness a commendable upsurge over 2024-2032, on account of the growing prevalence of osteoporosis worldwide. Healthcare providers are aiming to raise awareness of common bone conditions, that along with the expansion of the elderly population who are susceptible to falls and bone fractures will create lucrative prospects for joint padding system manufacturers worldwide. According to the WHO’s report, by 2030, 1 in 6 people aged will reach 60 years of age and above, with 80% of older people living in middle- and low-income countries.
The rising adoption of sedentary lifestyles and increasing incidences of obesity will become prominent factors influencing global orthopedic padding industry. Based on data from McLeod Orthopaedics, in the U.S., more than two-thirds of adults are obese or overweight. Since obesity is a common comorbidity among patients with orthopedic diseases, the growing disease prevalence will bolster the requirement for orthopedic pads for quick healing from fractures. Additionally, the increasing number of motor vehicle traffic crashes and roadway fatalities will accelerate the adoption of orthopedic paddings.
Orthopedic Padding Market Trends
There is growing preference for lightweight and breathable padding materials that offer enhanced comfort and flexibility for patients undergoing orthopedic procedures. Manufacturers are focusing on developing innovative padding solutions using advanced textiles and foams to provide optimal support and protection while minimizing bulkiness and discomfort. Additionally, product with antimicrobial properties is being developed to reduce the risk of infections and promote faster healing post-surgery. The digitalization and advancements in 3D scanning technology are revolutionizing the customization of orthopedic padding, enabling precise fitting and personalized treatment options for patients.
Orthopedic Padding Market Analysis
The orthopedic padding industry size from the polyester material segment is expected to grow through 2032, on account of the product’s high strength, softness, lightweight, and absorbent nature. Considering its stability and durability, polyester has also emerged as a viable option for undercast padding. Positive attributes associated with this material will result in its increased use over the forthcoming years.
The pharmacies distribution channel segment share will surge over the forecast period, given the rising internet penetration and the upsurge in e-pharmacy demand. Due to the surging competition across the health-tech sector, e-pharmacies are targeting to strengthen their partner networks. The expansion of healthcare infrastructure networks will further boost the development of hospital pharmacies and in turn, add impetus to industry growth over the forecast period.
Europe is set to become a key revenue hub for the orthopedic padding market between 2024 to 2032, on account of the rising prevalence of osteoporosis, especially among women. According to the Royal Osteoporosis Society, in 2022, 3.5 million people were diagnosed with osteoporosis. Furthermore, almost 1 in 2 women over 50 years of age are at risk of breaking a bone due to the condition in the UK. Road accidents have also become major causes of fatal casualties and injuries in major European economies such as Austria, leading to the mounting consumption of orthopedic cast padding solutions in the region.
Orthopedic Padding Market Share
Some of the prominent companies in the orthopedic padding industry include:
- Johnson & Johnson
- Kiyan International
- Cardinal Health Inc.
- BSN Medical Ltd.
- 3M
- McKesson Medical-Surgical
Innovative product launches, acquisitions, partnerships, and business expansions are among the strategies being adopted by these market participants to strengthen their presence and multiply revenues.
Orthopedic Padding Industry News
- In October 2023, Ilant Health, a company established to collaborate with employers and government payors to enhance obesity treatment through holistic, integrated, and value-based care, emerged from stealth with $3M in funding.